Literature DB >> 15048196

Structure and biological functions of fungal cerebrosides.

Eliana Barreto-Bergter1, Marcia R Pinto, Marcio L Rodrigues.   

Abstract

Ceramide monohexosides (CMHs, cerebrosides) are glycosphingolipids composed of a hydrophobic ceramide linked to one sugar unit. In fungal cells, CMHs are very conserved molecules consisting of a ceramide moiety containing 9-methyl-4,8-sphingadienine in amidic linkage to 2-hydroxyoctadecanoic or 2-hydroxyhexadecanoic acids, and a carbohydrate portion consisting of one residue of glucose or galactose. 9-Methyl 4,8-sphingadienine-containing ceramides are usually glycosylated to form fungal cerebrosides, but the recent description of a ceramide dihexoside (CDH) presenting phytosphingosine in Magnaporthe grisea suggests the existence of alternative pathways of ceramide glycosylation in fungal cells. Along with their unique structural characteristics, fungal CMHs have a peculiar subcellular distribution and striking biological properties. In Pseudallescheria boydii, Candida albicans, Cryptococcus neoformans, Aspergillus nidulans, A. fumigatus, and Schizophyllum commune, CMHs are apparently involved in morphological transitions and fungal growth. The elucidation of structural and functional aspects of fungal cerebrosides may therefore contribute to the design of new antifungal agents inhibiting growth and differentiation of pathogenic species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048196     DOI: 10.1590/s0001-37652004000100007

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  31 in total

1.  Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.

Authors:  Marcio L Rodrigues; Leonardo Nimrichter; Débora L Oliveira; Susana Frases; Kildare Miranda; Oscar Zaragoza; Mauricio Alvarez; Antonio Nakouzi; Marta Feldmesser; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2006-11-17

2.  Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.

Authors:  Leonardo Nimrichter; Mariana D Cerqueira; Eduardo A Leitão; Kildare Miranda; Ernesto S Nakayasu; Sandro R Almeida; Igor C Almeida; Celuta S Alviano; Eliana Barreto-Bergter; Marcio L Rodrigues
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.

Authors:  Ryan Rhome; Travis McQuiston; Talar Kechichian; Alicja Bielawska; Mirko Hennig; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2007-08-10

4.  Glycolipid sensing and innate immunity in paracoccidioidomycosis.

Authors:  Vanessa G Batista; Marcos S Toledo; Anita H Straus; Maria J S Mendes-Giannini; Alberto J S Duarte; Helio K Takahashi; Gil Benard
Journal:  Mycopathologia       Date:  2014-07-16       Impact factor: 2.574

5.  The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans.

Authors:  Karin Thevissen; Patricia de Mello Tavares; Deming Xu; Jill Blankenship; Davy Vandenbosch; Jolanta Idkowiak-Baldys; Gilmer Govaert; Anna Bink; Sonia Rozental; Piet W J de Groot; Talya R Davis; Carol A Kumamoto; Gabriele Vargas; Leonardo Nimrichter; Tom Coenye; Aaron Mitchell; Terry Roemer; Yusuf A Hannun; Bruno P A Cammue
Journal:  Mol Microbiol       Date:  2012-03-05       Impact factor: 3.501

6.  Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Δ8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity.

Authors:  C M Fernandes; P A de Castro; A Singh; F L Fonseca; M D Pereira; T V M Vila; G C Atella; S Rozental; M Savoldi; M Del Poeta; G H Goldman; E Kurtenbach
Journal:  Mol Microbiol       Date:  2016-08-25       Impact factor: 3.501

7.  Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.

Authors:  Marcio L Rodrigues; Li Shi; Eliana Barreto-Bergter; Leonardo Nimrichter; Sandra E Farias; Elaine G Rodrigues; Luiz R Travassos; Joshua D Nosanchuk
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

8.  In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis.

Authors:  Patricia M Tavares; Karin Thevissen; Bruno P A Cammue; Isabelle E J A François; Eliana Barreto-Bergter; Carlos P Taborda; Alexandre F Marques; Marcio L Rodrigues; Leonardo Nimrichter
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

Review 9.  How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.

Authors:  Tamara Lea Doering
Journal:  Annu Rev Microbiol       Date:  2009       Impact factor: 15.500

Review 10.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.